Biotechnology
The Biotechnology industry has a total of 589 stocks, with a combined market cap of $1.09 trillion and total revenue of $110.29 billion.
Market Cap
1.09T
Revenue
110.29B
Profits
-41.77B
PE Ratio
n/a
Profit Margin
-37.88%
Dividend Yield
0.04%
589 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 110.23B | -0.52% | 1,219,541 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 64.13B | 0.10% | 1,444,842 | 14.92B |
| 3 | ARGX | argenx SE | 49.39B | 2.77% | 290,926 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.29B | 2.81% | 770,305 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 33.02B | 1.34% | 219,133 | 5.70B |
| 6 | RVMD | Revolution Medicines, Inc. | 31.32B | 2.03% | 1,710,552 | - |
| 7 | RPRX | Royalty Pharma plc | 30.18B | 0.65% | 3,808,472 | 2.44B |
| 8 | INSM | Insmed Incorporated | 23.28B | 0.24% | 3,647,285 | 819.56M |
| 9 | BNTX | BioNTech SE | 22.20B | -1.19% | 774,522 | 3.23B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.19B | -1.19% | 4,132,238 | 13.31M |
| 11 | INCY | Incyte Corporation | 19.10B | 0.43% | 1,166,639 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 18.14B | -4.97% | 5,452,258 | 2.23B |
| 13 | GMAB | Genmab A/S | 15.79B | -2.62% | 4,339,280 | 3.90B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 14.90B | 3.44% | 1,268,544 | 4.44B |
| 15 | ASND | Ascendis Pharma A/S | 14.78B | 0.14% | 507,658 | 998.25M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 12.93B | 1.04% | 2,420,249 | 579.96M |
| 17 | SMMT | Summit Therapeutics Inc. | 12.30B | -1.06% | 2,644,207 | - |
| 18 | EXEL | Exelixis, Inc. | 12.23B | -2.35% | 2,843,822 | 2.38B |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 12.20B | 1.82% | 1,519,487 | 1.06B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.80B | -1.99% | 258,876 | 1.13B |
| 21 | AXSM | Axsome Therapeutics, Inc. | 11.66B | -0.32% | 510,240 | 708.24M |
| 22 | CYTK | Cytokinetics, Incorporated | 10.38B | 1.69% | 2,399,086 | 105.82M |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.31B | -1.04% | 2,121,022 | 622.01M |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 9.63B | 0.28% | 2,598,637 | 3.24B |
| 25 | ABVX | ABIVAX Société Anonyme | 8.97B | 0.16% | 1,102,971 | 5.37M |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 8.94B | 0.02% | 300,530 | 7.46M |
| 27 | KRYS | Krystal Biotech, Inc. | 8.65B | 0.53% | 191,189 | 417.30M |
| 28 | HALO | Halozyme Therapeutics, Inc. | 8.15B | 1.91% | 2,004,304 | 1.51B |
| 29 | IBRX | ImmunityBio, Inc. | 8.13B | -3.00% | 17,883,517 | 140.98M |
| 30 | NUVL | Nuvalent, Inc. | 7.98B | 1.10% | 560,739 | - |
| 31 | TECH | Bio-Techne Corporation | 7.12B | 2.34% | 3,381,907 | 1.21B |
| 32 | PCVX | Vaxcyte, Inc. | 7.04B | 0.70% | 1,065,762 | - |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.43B | -1.92% | 587,743 | 51.48M |
| 34 | CELC | Celcuity Inc. | 6.39B | -0.92% | 640,861 | - |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.33B | -2.35% | 492,707 | 74.06M |
| 36 | CORT | Corcept Therapeutics Incorporated | 6.25B | 5.62% | 1,498,390 | 769.10M |
| 37 | CNTA | Centessa Pharmaceuticals plc | 6.14B | 0.15% | 787,624 | 15.00M |
| 38 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.98B | 0.43% | 527,830 | 217.17M |
| 39 | APGE | Apogee Therapeutics, Inc. | 5.87B | -0.61% | 976,486 | - |
| 40 | MIRM | Mirum Pharmaceuticals, Inc. | 5.83B | 0.17% | 1,312,494 | 569.61M |
| 41 | PTCT | PTC Therapeutics, Inc. | 5.83B | 0.19% | 725,212 | 827.11M |
| 42 | SYRE | Spyre Therapeutics, Inc. | 5.79B | -4.94% | 1,385,678 | - |
| 43 | SRRK | Scholar Rock Holding Corporation | 5.70B | 0.38% | 873,602 | - |
| 44 | TGTX | TG Therapeutics, Inc. | 5.59B | -0.13% | 1,223,699 | 700.35M |
| 45 | CGON | CG Oncology, Inc. | 5.58B | 0.59% | 675,117 | 5.07M |
| 46 | BLTE | Belite Bio, Inc | 5.50B | -2.24% | 190,345 | - |
| 47 | IMVT | Immunovant, Inc. | 5.35B | -0.90% | 1,444,360 | - |
| 48 | COGT | Cogent Biosciences, Inc. | 5.34B | -0.35% | 2,819,207 | - |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.22B | 0.63% | 852,789 | 7.50M |
| 50 | LEGN | Legend Biotech Corporation | 5.00B | -0.15% | 1,154,406 | 1.14B |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 4.68B | 2.48% | 531,837 | 1.34M |
| 52 | CRSP | CRISPR Therapeutics AG | 4.59B | -2.00% | 1,473,546 | 4.10M |
| 53 | CAI | Caris Life Sciences, Inc. | 4.23B | -0.93% | 2,460,715 | 907.29M |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 4.16B | -0.05% | 198,728 | 274.48M |
| 55 | MANE | Veradermics, Incorporated | 4.12B | -0.31% | 289,837 | - |
| 56 | TVTX | Travere Therapeutics, Inc. | 3.93B | -1.47% | 1,294,000 | 536.20M |
| 57 | NAMS | NewAmsterdam Pharma Company N.V. | 3.88B | -1.23% | 2,085,060 | 22.57M |
| 58 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.82B | -0.06% | 2,976,937 | 596.96M |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.68B | 0.69% | 932,237 | 18.07M |
| 60 | ACAD | ACADIA Pharmaceuticals Inc. | 3.51B | -1.01% | 2,089,299 | 1.10B |
| 61 | ORKA | Oruka Therapeutics, Inc. | 3.47B | -1.44% | 2,254,759 | - |
| 62 | TLX | Telix Pharmaceuticals Limited | 3.42B | -1.07% | 81,089 | 803.79M |
| 63 | EWTX | Edgewise Therapeutics, Inc. | 3.38B | -0.91% | 971,830 | - |
| 64 | VKTX | Viking Therapeutics, Inc. | 3.30B | -1.01% | 1,802,450 | - |
| 65 | ERAS | Erasca, Inc. | 3.21B | 0.49% | 4,019,712 | - |
| 66 | TNGX | Tango Therapeutics, Inc. | 2.94B | -1.60% | 1,917,530 | 56.99M |
| 67 | DNLI | Denali Therapeutics Inc. | 2.87B | -1.58% | 2,130,798 | - |
| 68 | RCUS | Arcus Biosciences, Inc. | 2.86B | -2.78% | 754,549 | 236.00M |
| 69 | SLNO | Soleno Therapeutics, Inc. | 2.76B | - | - | 285.01M |
| 70 | ALMS | Alumis Inc. | 2.74B | 1.77% | 1,335,577 | 8.40M |
| 71 | TARS | Tarsus Pharmaceuticals, Inc. | 2.64B | -2.44% | 640,654 | 535.08M |
| 72 | DYN | Dyne Therapeutics, Inc. | 2.63B | -3.75% | 1,689,053 | - |
| 73 | BEAM | Beam Therapeutics Inc. | 2.62B | -1.79% | 1,488,012 | 164.01M |
| 74 | GPCR | Structure Therapeutics Inc. | 2.55B | -0.64% | 593,728 | - |
| 75 | KLRA | Kailera Therapeutics, Inc. | 2.54B | 0.36% | 347,813 | - |
| 76 | IDYA | IDEAYA Biosciences, Inc. | 2.49B | - | 597,788 | 225.27M |
| 77 | IRON | Disc Medicine, Inc. | 2.45B | -4.16% | 671,709 | - |
| 78 | ELVN | Enliven Therapeutics, Inc. | 2.45B | 1.36% | 574,183 | - |
| 79 | ARQT | Arcutis Biotherapeutics, Inc. | 2.44B | -2.65% | 4,512,129 | 415.62M |
| 80 | VERA | Vera Therapeutics, Inc. | 2.39B | -3.20% | 1,285,033 | - |
| 81 | CLDX | Celldex Therapeutics, Inc. | 2.37B | -0.23% | 566,904 | 865.00K |
| 82 | RLAY | Relay Therapeutics, Inc. | 2.31B | -0.25% | 17,053,012 | 10.68M |
| 83 | NKTR | Nektar Therapeutics | 2.28B | -1.24% | 883,460 | 55.63M |
| 84 | IMNM | Immunome, Inc. | 2.23B | -1.21% | 765,376 | 4.02M |
| 85 | RARE | Ultragenyx Pharmaceutical Inc. | 2.20B | -7.19% | 2,121,072 | 670.00M |
| 86 | DFTX | Definium Therapeutics, Inc. | 2.18B | -2.25% | 1,498,442 | - |
| 87 | NBTX | Nanobiotix S.A. | 2.16B | -6.63% | 72,752 | 38.27M |
| 88 | KOD | Kodiak Sciences Inc. | 2.15B | -1.71% | 1,081,184 | - |
| 89 | MLYS | Mineralys Therapeutics, Inc. | 2.15B | -1.33% | 703,156 | - |
| 90 | ZLAB | Zai Lab Limited | 2.06B | -2.60% | 626,580 | 453.28M |
| 91 | TYRA | Tyra Biosciences, Inc. | 2.01B | -5.27% | 1,110,135 | - |
| 92 | ADMA | ADMA Biologics, Inc. | 2.00B | 2.98% | 3,074,551 | 509.86M |
| 93 | AUPH | Aurinia Pharmaceuticals Inc. | 2.00B | -0.32% | 775,616 | 298.30M |
| 94 | PHVS | Pharvaris N.V. | 1.89B | 0.28% | 301,434 | - |
| 95 | TRVI | Trevi Therapeutics, Inc. | 1.88B | -1.41% | 1,215,897 | - |
| 96 | MESO | Mesoblast Limited | 1.87B | -0.68% | 140,139 | 65.38M |
| 97 | STOK | Stoke Therapeutics, Inc. | 1.87B | 3.20% | 704,561 | 32.08M |
| 98 | ZYME | Zymeworks Inc. | 1.78B | -0.12% | 615,320 | 81.26M |
| 99 | AAPG | Ascentage Pharma Group International | 1.77B | 2.32% | 6,549 | 82.08M |
| 100 | VRDN | Viridian Therapeutics, Inc. | 1.76B | -0.81% | 1,796,011 | 70.92M |
| 101 | HRMY | Harmony Biosciences Holdings, Inc. | 1.76B | 2.04% | 713,716 | 899.11M |
| 102 | VCEL | Vericel Corporation | 1.76B | -1.09% | 565,650 | 292.09M |
| 103 | LKFT | Lakefront Biotherapeutics NV | 1.76B | -0.30% | 177,421 | 1.20B |
| 104 | SRPT | Sarepta Therapeutics, Inc. | 1.76B | -2.18% | 1,826,774 | 2.18B |
| 105 | OCUL | Ocular Therapeutix, Inc. | 1.75B | -4.65% | 2,959,641 | 52.04M |
| 106 | ANAB | AnaptysBio, Inc. | 1.74B | 1.75% | 414,250 | 232.39M |
| 107 | SNDX | Syndax Pharmaceuticals, Inc. | 1.72B | -0.26% | 929,951 | 217.17M |
| 108 | SION | Sionna Therapeutics, Inc. | 1.70B | -3.98% | 313,512 | - |
| 109 | NTLA | Intellia Therapeutics, Inc. | 1.67B | -5.91% | 5,520,515 | 66.09M |
| 110 | OCS | Oculis Holding AG | 1.65B | -0.39% | 290,490 | 1.40M |
| 111 | AGIO | Agios Pharmaceuticals, Inc. | 1.65B | -1.70% | 637,998 | 66.05M |
| 112 | RAPP | Rapport Therapeutics, Inc. | 1.64B | -2.27% | 307,006 | 20.00M |
| 113 | INBX | Inhibrx Biosciences, Inc. | 1.61B | 3.51% | 303,425 | 1.30M |
| 114 | INVA | Innoviva, Inc. | 1.60B | -0.32% | 809,268 | 420.69M |
| 115 | GENB | Generate Biomedicines, Inc. | 1.58B | -4.50% | 687,358 | 30.30M |
| 116 | NRIX | Nurix Therapeutics, Inc. | 1.58B | -1.74% | 1,060,380 | 71.78M |
| 117 | PVLA | Palvella Therapeutics, Inc. | 1.57B | 3.95% | 208,424 | - |
| 118 | CAPR | Capricor Therapeutics, Inc. | 1.56B | -3.91% | 1,103,182 | 11.13M |
| 119 | QURE | uniQure N.V. | 1.56B | -0.96% | 872,076 | 18.09M |
| 120 | IOVA | Iovance Biotherapeutics, Inc. | 1.54B | 2.06% | 8,589,442 | 285.61M |
| 121 | RXRX | Recursion Pharmaceuticals, Inc. | 1.51B | -1.38% | 16,003,597 | 66.41M |
| 122 | GHRS | GH Research PLC | 1.51B | 1.20% | 372,890 | - |
| 123 | ARDX | Ardelyx, Inc. | 1.50B | -0.33% | 2,357,868 | 427.68M |
| 124 | TSHA | Taysha Gene Therapies, Inc. | 1.49B | -4.78% | 2,308,475 | 7.47M |
| 125 | GLUE | Monte Rosa Therapeutics, Inc. | 1.49B | -2.39% | 640,384 | 42.95M |
| 126 | PGEN | Precigen, Inc. | 1.48B | 2.21% | 2,677,264 | 31.60M |
| 127 | NUVB | Nuvation Bio Inc. | 1.48B | 0.71% | 4,538,519 | 143.05M |
| 128 | IMCR | Immunocore Holdings plc | 1.47B | 1.97% | 308,056 | 412.81M |
| 129 | NVAX | Novavax, Inc. | 1.46B | -0.34% | 2,499,285 | 596.34M |
| 130 | ATAI | AtaiBeckley Inc. | 1.45B | -4.58% | 4,555,251 | 3.49M |
| 131 | DMRA | Damora Therapeutics, Inc. | 1.45B | -3.45% | 249,544 | - |
| 132 | MBX | MBX Biosciences, Inc. | 1.45B | -1.90% | 610,126 | - |
| 133 | VIR | Vir Biotechnology, Inc. | 1.44B | -2.74% | 1,536,076 | 65.50M |
| 134 | IMTX | Immatics N.V. | 1.43B | 0.75% | 668,582 | 43.00M |
| 135 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | 0.04% | 8,048,372 | 114.48M |
| 136 | SLS | SELLAS Life Sciences Group, Inc. | 1.41B | 4.12% | 7,854,841 | - |
| 137 | URGN | UroGen Pharma Ltd. | 1.38B | -1.12% | 555,477 | 140.49M |
| 138 | MAZE | Maze Therapeutics, Inc. | 1.35B | -0.16% | 470,141 | 20.00M |
| 139 | BCAX | Bicara Therapeutics Inc. | 1.32B | 3.86% | 429,827 | - |
| 140 | FTRE | Fortrea Holdings Inc. | 1.30B | 0.99% | 873,659 | 2.71B |
| 141 | BHVN | Biohaven Ltd. | 1.26B | -1.18% | 1,213,261 | - |
| 142 | ABCL | AbCellera Biologics Inc. | 1.24B | -2.64% | 4,590,606 | 79.21M |
| 143 | MPLT | MapLight Therapeutics, Inc. | 1.23B | 2.19% | 186,520 | - |
| 144 | AVBP | ArriVent BioPharma, Inc. | 1.22B | -3.22% | 435,380 | - |
| 145 | SVRA | Savara Inc. | 1.20B | -3.87% | 1,080,988 | - |
| 146 | SEPN | Septerna, Inc. | 1.19B | 0.80% | 366,751 | 72.26M |
| 147 | MLTX | MoonLake Immunotherapeutics | 1.19B | -0.43% | 1,008,301 | - |
| 148 | WVE | Wave Life Sciences Ltd. | 1.18B | -4.06% | 8,084,951 | 71.80M |
| 149 | AVLN | Avalyn Pharma Inc. | 1.18B | 5.56% | 126,126 | - |
| 150 | OLMA | Olema Pharmaceuticals, Inc. | 1.14B | 1.55% | 962,439 | - |
| 151 | ZBIO | Zenas BioPharma, Inc. | 1.13B | 5.50% | 659,030 | 10.00M |
| 152 | COAG | Hemab Therapeutics Holdings, Inc. | 1.12B | -6.30% | 132,592 | - |
| 153 | DBVT | DBV Technologies S.A. | 1.10B | -1.57% | 118,121 | 5.74M |
| 154 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.09B | 3.43% | 1,999,925 | 204.73M |
| 155 | JBIO | Jade Biosciences, Inc. | 1.08B | -0.59% | 931,478 | - |
| 156 | IVA | Inventiva S.A. | 1.02B | -2.19% | 273,776 | 7.94M |
| 157 | AKTS | Aktis Oncology, Inc. | 1.02B | -0.59% | 194,409 | 8.28M |
| 158 | EYPT | EyePoint, Inc. | 991.00M | 1.03% | 736,322 | 7.61M |
| 159 | CRVS | Corvus Pharmaceuticals, Inc. | 967.04M | -5.81% | 3,920,716 | - |
| 160 | LXRX | Lexicon Pharmaceuticals, Inc. | 945.94M | -0.47% | 1,646,458 | 69.64M |
| 161 | DRTS | Alpha Tau Medical Ltd. | 939.94M | 6.48% | 978,438 | - |
| 162 | MNKD | MannKind Corporation | 914.49M | -1.00% | 4,549,094 | 360.78M |
| 163 | PHAT | Phathom Pharmaceuticals, Inc. | 905.50M | 0.09% | 1,010,950 | 204.89M |
| 164 | PHAR | Pharming Group N.V. | 895.41M | -0.16% | 7,602 | 369.49M |
| 165 | CGEM | Cullinan Therapeutics, Inc. | 871.17M | -4.67% | 1,098,079 | - |
| 166 | OMER | Omeros Corporation | 866.33M | 2.31% | 1,255,037 | 9.89M |
| 167 | SANA | Sana Biotechnology, Inc. | 851.57M | 0.66% | 3,029,875 | - |
| 168 | MGTX | MeiraGTx Holdings plc | 845.52M | -2.87% | 3,016,935 | 79.76M |
| 169 | JANX | Janux Therapeutics, Inc. | 842.19M | -1.57% | 3,532,001 | 13.73M |
| 170 | TBPH | Theravance Biopharma, Inc. | 837.74M | -0.06% | 313,848 | 109.78M |
| 171 | SPTX | Seaport Therapeutics, Inc. | 832.01M | -0.32% | 158,911 | - |
| 172 | ABUS | Arbutus Biopharma Corporation | 829.66M | 0.72% | 677,079 | 191.45M |
| 173 | ORIC | ORIC Pharmaceuticals, Inc. | 825.03M | 0.50% | 824,742 | - |
| 174 | AURA | Aura Biosciences, Inc. | 815.11M | -1.07% | 555,369 | - |
| 175 | ANNX | Annexon, Inc. | 804.47M | -1.01% | 2,576,058 | - |
| 176 | ODTX | Odyssey Therapeutics, Inc. | 799.13M | -2.59% | 376,526 | 2.98M |
| 177 | AVTX | Avalo Therapeutics, Inc. | 798.15M | 0.68% | 1,560,134 | 59.00K |
| 178 | KURA | Kura Oncology, Inc. | 795.42M | -2.61% | 1,402,192 | 71.64M |
| 179 | CTMX | CytomX Therapeutics, Inc. | 792.44M | 4.00% | 6,760,231 | 35.54M |
| 180 | GERN | Geron Corporation | 782.66M | -0.81% | 10,550,464 | 196.12M |
| 181 | LBRX | LB Pharmaceuticals Inc | 782.01M | -1.69% | 164,554 | - |
| 182 | XNCR | Xencor, Inc. | 771.81M | -5.88% | 793,569 | 97.36M |
| 183 | VOR | Vor Biopharma Inc. | 764.56M | -0.14% | 714,217 | - |
| 184 | EVMN | Evommune, Inc. | 760.71M | -3.52% | 383,521 | 10.00M |
| 185 | DRUG | Bright Minds Biosciences Inc. | 737.61M | -0.61% | 235,565 | - |
| 186 | RLMD | Relmada Therapeutics, Inc. | 737.36M | 10.88% | 1,403,814 | - |
| 187 | ABSI | Absci Corporation | 721.84M | -6.37% | 4,251,656 | 1.84M |
| 188 | ANRO | Alto Neuroscience, Inc. | 716.83M | -6.19% | 330,310 | - |
| 189 | SPRY | ARS Pharmaceuticals, Inc. | 712.00M | -1.78% | 1,604,310 | 98.99M |
| 190 | SGP | SpyGlass Pharma, Inc. | 708.64M | -4.68% | 45,165 | - |
| 191 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 697.89M | -0.34% | 629,645 | - |
| 192 | TENX | Tenax Therapeutics, Inc. | 675.63M | -1.25% | 356,508 | - |
| 193 | DSGN | Design Therapeutics, Inc. | 655.17M | -1.96% | 2,165,370 | - |
| 194 | ALLO | Allogene Therapeutics, Inc. | 652.34M | -2.58% | 7,155,208 | 22.00K |
| 195 | ACRS | Aclaris Therapeutics, Inc. | 621.50M | 1.14% | 1,107,753 | 8.37M |
| 196 | CBIO | Crescent Biopharma, Inc. | 614.07M | -0.38% | 127,955 | 11.88M |
| 197 | CRMD | CorMedix Inc. | 613.49M | -1.14% | 1,737,225 | 400.05M |
| 198 | ZVRA | Zevra Therapeutics, Inc. | 602.97M | -2.21% | 2,541,566 | 122.29M |
| 199 | SLDB | Solid Biosciences Inc. | 598.57M | -6.61% | 1,831,830 | - |
| 200 | TRAX | First Tracks Biotherapeutics, Inc. | 581.31M | -6.35% | 508,975 | - |
| 201 | EIKN | Eikon Therapeutics, Inc. | 576.03M | -9.45% | 428,111 | - |
| 202 | GYRE | Gyre Therapeutics, Inc. | 571.99M | -2.80% | 92,693 | 117.05M |
| 203 | CADL | Candel Therapeutics, Inc. | 561.25M | -3.04% | 1,944,371 | - |
| 204 | ARVN | Arvinas, Inc. | 551.66M | -2.62% | 1,480,152 | 89.40M |
| 205 | MDXG | MiMedx Group, Inc. | 542.16M | 1.39% | 1,228,812 | 389.42M |
| 206 | VALN | Valneva SE | 537.83M | 0.70% | 45,717 | 180.25M |
| 207 | CABA | Cabaletta Bio, Inc. | 533.17M | -0.61% | 2,753,654 | - |
| 208 | ALT | Altimmune, Inc. | 532.86M | -2.14% | 2,512,579 | 36.00K |
| 209 | KYTX | Kyverna Therapeutics, Inc. | 526.61M | 1.87% | 1,038,664 | - |
| 210 | STRO | Sutro Biopharma, Inc. | 524.70M | -8.15% | 729,422 | 99.61M |
| 211 | RIGL | Rigel Pharmaceuticals, Inc. | 523.61M | -1.08% | 386,852 | 299.77M |
| 212 | XOMA | XOMA Royalty Corporation | 521.08M | -0.22% | 121,743 | 48.56M |
| 213 | AGMB | AgomAb Therapeutics NV | 517.60M | -0.47% | 29,563 | - |
| 214 | TECX | Tectonic Therapeutic, Inc. | 514.94M | -1.48% | 215,831 | - |
| 215 | FBRX | Forte Biosciences, Inc. | 490.42M | -4.29% | 323,706 | - |
| 216 | PRME | Prime Medicine, Inc. | 487.67M | -3.91% | 2,235,210 | 4.03M |
| 217 | DNA | Ginkgo Bioworks Holdings, Inc. | 480.79M | -0.14% | 751,606 | 151.40M |
| 218 | CTNM | Contineum Therapeutics, Inc. | 477.05M | -0.78% | 102,560 | - |
| 219 | PRTA | Prothena Corporation plc | 474.84M | -5.42% | 627,299 | 57.94M |
| 220 | IMMX | Immix Biopharma, Inc. | 469.69M | -1.45% | 1,052,636 | - |
| 221 | PROK | ProKidney Corp. | 468.04M | -3.73% | 848,288 | 889.00K |
| 222 | CLYM | Climb Bio, Inc. | 460.97M | -2.33% | 516,038 | - |
| 223 | ACHV | Achieve Life Sciences, Inc. | 456.83M | -6.71% | 1,309,298 | - |
| 224 | VTVT | vTv Therapeutics Inc. | 452.82M | 2.82% | 65,400 | 36.84M |
| 225 | OCGN | Ocugen, Inc. | 440.08M | -2.99% | 5,554,104 | 4.47M |
| 226 | FDMT | 4D Molecular Therapeutics, Inc. | 439.38M | 0.48% | 873,727 | 88.24M |
| 227 | STTK | Shattuck Labs, Inc. | 437.62M | -3.02% | 625,036 | 1.00M |
| 228 | UPB | Upstream Bio, Inc. | 436.99M | -5.64% | 853,221 | 3.32M |
| 229 | AUTL | Autolus Therapeutics plc | 433.81M | -9.44% | 1,709,442 | 92.62M |
| 230 | PRLD | Prelude Therapeutics Incorporated | 429.47M | -1.61% | 404,328 | 16.72M |
| 231 | ANL | Adlai Nortye Ltd. | 428.00M | -7.84% | 354,060 | 5.00M |
| 232 | NGNE | Neurogene Inc. | 424.76M | -3.93% | 150,058 | 925.00K |
| 233 | PRTC | PureTech Health plc | 423.21M | 2.09% | 21,280 | 4.66M |
| 234 | ASMB | Assembly Biosciences, Inc. | 421.47M | -3.28% | 116,170 | 71.10M |
| 235 | ARTV | Artiva Biotherapeutics, Inc. | 415.43M | -7.27% | 844,926 | 251.00K |
| 236 | OVID | Ovid Therapeutics Inc. | 415.29M | -0.41% | 1,501,271 | 7.12M |
| 237 | SGMT | Sagimet Biosciences Inc. | 403.86M | -1.80% | 876,884 | - |
| 238 | ENTA | Enanta Pharmaceuticals, Inc. | 400.12M | 2.30% | 203,871 | 69.21M |
| 239 | ADCT | ADC Therapeutics SA | 399.38M | -0.95% | 753,571 | 79.18M |
| 240 | FULC | Fulcrum Therapeutics, Inc. | 393.80M | -2.96% | 400,169 | 80.00M |
| 241 | EPRX | Eupraxia Pharmaceuticals Inc. | 391.44M | -5.98% | 485,308 | - |
| 242 | REPL | Replimune Group, Inc. | 388.09M | -6.19% | 3,917,346 | - |
| 243 | IPSC | Century Therapeutics, Inc. | 382.35M | -6.36% | 930,584 | 109.16M |
| 244 | ZURA | Zura Bio Limited | 378.57M | -3.16% | 649,495 | - |
| 245 | LYEL | Lyell Immunopharma, Inc. | 376.35M | -2.30% | 119,022 | 31.00K |
| 246 | MNPR | Monopar Therapeutics Inc. | 369.77M | -1.87% | 251,859 | - |
| 247 | BNTC | Benitec Biopharma Inc. | 368.28M | -1.56% | 88,162 | - |
| 248 | VSTM | Verastem, Inc. | 364.68M | -2.58% | 1,732,782 | 49.59M |
| 249 | GLSI | Greenwich LifeSciences, Inc. | 364.51M | -2.12% | 91,226 | - |
| 250 | VNDA | Vanda Pharmaceuticals Inc. | 360.21M | -1.48% | 651,735 | 217.78M |
| 251 | LXEO | Lexeo Therapeutics, Inc. | 351.78M | -4.88% | 1,020,911 | - |
| 252 | YDES | YD Bio Limited | 351.21M | -1.29% | 8,262 | 510.36K |
| 253 | IFRX | InflaRx N.V. | 349.08M | -5.20% | 1,299,501 | 33.82K |
| 254 | LRMR | Larimar Therapeutics, Inc. | 347.60M | 2.78% | 1,836,265 | - |
| 255 | PBYI | Puma Biotechnology, Inc. | 346.63M | - | 166,159 | 227.18M |
| 256 | OABI | OmniAb, Inc. | 343.59M | 3.49% | 1,145,742 | 28.94M |
| 257 | XFOR | X4 Pharmaceuticals, Inc. | 343.32M | -1.09% | 446,911 | 9.01M |
| 258 | CCCC | C4 Therapeutics, Inc. | 342.66M | -3.42% | 1,812,236 | 34.86M |
| 259 | FENC | Fennec Pharmaceuticals Inc. | 339.03M | 1.67% | 288,987 | 51.00M |
| 260 | AVIR | Atea Pharmaceuticals, Inc. | 332.11M | 0.24% | 250,594 | - |
| 261 | CMPX | Compass Therapeutics, Inc. | 325.96M | -1.09% | 3,731,750 | 850.00K |
| 262 | RZLT | Rezolute, Inc. | 323.85M | -4.32% | 2,015,796 | - |
| 263 | RCKT | Rocket Pharmaceuticals, Inc. | 318.85M | -4.89% | 2,660,628 | - |
| 264 | IMRX | Immuneering Corporation | 316.37M | 0.41% | 696,755 | - |
| 265 | ARMP | Armata Pharmaceuticals, Inc. | 310.44M | 11.32% | 92,519 | 5.20M |
| 266 | NMRA | Neumora Therapeutics, Inc. | 305.09M | -5.65% | 918,833 | - |
| 267 | IRD | Opus Genetics, Inc. | 304.17M | -4.05% | 840,683 | 11.98M |
| 268 | BCYC | Bicycle Therapeutics plc | 303.23M | -0.23% | 365,514 | 63.50M |
| 269 | PALI | Palisade Bio, Inc. | 303.04M | - | 2,854,040 | - |
| 270 | NAUT | Nautilus Biotechnology, Inc. | 302.45M | 0.85% | 328,631 | - |
| 271 | DMAC | DiaMedica Therapeutics Inc. | 300.13M | -1.94% | 144,553 | - |
| 272 | LCTX | Lineage Cell Therapeutics, Inc. | 299.16M | -3.23% | 1,141,940 | 14.78M |
| 273 | IVVD | Invivyd, Inc. | 294.12M | -7.96% | 2,805,749 | 55.87M |
| 274 | SRZN | Surrozen, Inc. | 293.72M | -6.81% | 196,293 | 7.49M |
| 275 | NAGE | Niagen Bioscience, Inc. | 292.91M | -0.81% | 547,556 | 130.42M |
| 276 | RGNX | REGENXBIO Inc. | 292.61M | 0.18% | 1,783,204 | 87.82M |
| 277 | ABEO | Abeona Therapeutics Inc. | 291.82M | -4.66% | 1,718,293 | 14.54M |
| 278 | NGEN | NervGen Pharma Corp. | 288.11M | -2.20% | 88,340 | - |
| 279 | MGNX | MacroGenics, Inc. | 287.29M | 3.91% | 1,625,394 | 157.08M |
| 280 | ACIU | AC Immune SA | 279.75M | 1.81% | 272,401 | 4.62M |
| 281 | ELDN | Eledon Pharmaceuticals, Inc. | 276.74M | - | 873,253 | - |
| 282 | NVCT | Nuvectis Pharma, Inc. | 273.21M | -0.96% | 88,708 | - |
| 283 | SLN | Silence Therapeutics plc | 272.54M | -7.38% | 269,600 | 839.00K |
| 284 | CLLS | Cellectis S.A. | 272.52M | -5.71% | 52,256 | 75.11M |
| 285 | IKT | Inhibikase Therapeutics, Inc. | 267.56M | -2.48% | 1,367,210 | 1.00 |
| 286 | ALXO | ALX Oncology Holdings Inc. | 263.74M | -2.00% | 628,975 | - |
| 287 | CGEN | Compugen Ltd. | 258.13M | -4.55% | 956,021 | 72.66M |
| 288 | ZNTL | Zentalis Pharmaceuticals, Inc. | 252.00M | -2.48% | 826,534 | 26.87M |
| 289 | SABS | SAB Biotherapeutics, Inc. | 249.48M | -0.28% | 487,791 | 114.70K |
| 290 | AVXL | Anavex Life Sciences Corp. | 247.43M | -7.29% | 1,563,174 | - |
| 291 | TARA | Protara Therapeutics, Inc. | 243.93M | -5.65% | 497,042 | - |
| 292 | EDIT | Editas Medicine, Inc. | 240.85M | -2.77% | 909,436 | 38.69M |
| 293 | OBIO | Orchestra BioMed Holdings, Inc. | 239.52M | 0.50% | 490,675 | 32.72M |
| 294 | ALEC | Alector, Inc. | 234.26M | -0.47% | 790,426 | 18.42M |
| 295 | CHRS | Coherus Oncology, Inc. | 228.29M | -0.67% | 1,292,404 | 46.88M |
| 296 | ADAG | Adagene Inc. | 224.65M | 0.29% | 32,945 | 7.67M |
| 297 | CDXS | Codexis, Inc. | 223.61M | -3.53% | 659,683 | 78.09M |
| 298 | RNA | Atrium Therapeutics, Inc. | 221.52M | - | 273,070 | 36.68M |
| 299 | FATE | Fate Therapeutics, Inc. | 220.30M | 9.25% | 5,850,395 | 6.32M |
| 300 | TNXP | Tonix Pharmaceuticals Holding Corp. | 218.55M | -3.86% | 277,290 | 17.56M |
| 301 | CAMP | Camp4 Therapeutics Corporation | 215.49M | -8.99% | 47,284 | 3.93M |
| 302 | MDWD | MediWound Ltd. | 214.44M | 1.74% | 35,497 | 16.96M |
| 303 | FHTX | Foghorn Therapeutics Inc. | 211.37M | -5.76% | 177,544 | 28.22M |
| 304 | VYGR | Voyager Therapeutics, Inc. | 210.27M | -1.42% | 959,740 | 36.49M |
| 305 | HELP | Cybin Inc. | 209.15M | -5.86% | 915,442 | - |
| 306 | LENZ | LENZ Therapeutics, Inc. | 208.51M | -3.62% | 711,472 | 20.99M |
| 307 | SLGL | Sol-Gel Technologies Ltd. | 206.96M | -7.37% | 12,161 | 19.39M |
| 308 | UNCY | Unicycive Therapeutics, Inc. | 206.39M | -5.15% | 598,214 | - |
| 309 | TRDA | Entrada Therapeutics, Inc. | 203.59M | -4.07% | 378,151 | 5.74M |
| 310 | NERV | Minerva Neurosciences, Inc. | 203.13M | -8.02% | 303,838 | - |
| 311 | WHWK | Whitehawk Therapeutics, Inc. | 201.17M | -4.24% | 239,434 | 7.15M |
| 312 | CNTX | Context Therapeutics Inc. | 199.38M | 0.93% | 407,958 | - |
| 313 | IPHA | Innate Pharma S.A. | 196.91M | -9.78% | 78,567 | 10.57M |
| 314 | KROS | Keros Therapeutics, Inc. | 196.14M | -2.46% | 413,207 | 33.18M |
| 315 | MIST | Milestone Pharmaceuticals Inc. | 194.55M | -2.05% | 1,293,780 | 1.78M |
| 316 | NBP | NovaBridge Biosciences | 194.29M | -1.75% | 1,153,239 | - |
| 317 | CRBU | Caribou Biosciences, Inc. | 193.57M | -4.83% | 1,743,448 | 11.20M |
| 318 | NKTX | Nkarta, Inc. | 191.74M | - | 683,286 | - |
| 319 | ARCT | Arcturus Therapeutics Holdings Inc. | 190.15M | -4.84% | 497,931 | 54.71M |
| 320 | CNTN | Canton Strategic Holdings, Inc. | 184.98M | 0.15% | 357,124 | - |
| 321 | HUMA | Humacyte, Inc. | 183.23M | -8.14% | 4,185,060 | 2.02M |
| 322 | RNAC | Cartesian Therapeutics, Inc. | 178.93M | -11.61% | 208,721 | 1.78M |
| 323 | DTIL | Precision BioSciences, Inc. | 178.04M | -0.86% | 189,465 | 45.07M |
| 324 | TLSA | Tiziana Life Sciences Ltd | 176.12M | 2.22% | 247,033 | - |
| 325 | ORMP | Oramed Pharmaceuticals Inc. | 175.13M | 0.93% | 285,954 | 2.00M |
| 326 | BDTX | Black Diamond Therapeutics, Inc. | 171.91M | 16.28% | 1,898,740 | 70.00M |
| 327 | TNYA | Tenaya Therapeutics, Inc. | 170.89M | 0.57% | 2,957,753 | 225.00K |
| 328 | ENLV | Enlivex Ltd. | 169.82M | 1.03% | 97,159 | - |
| 329 | ELTX | Elicio Therapeutics, Inc. | 168.69M | -4.18% | 129,804 | - |
| 330 | KPTI | Karyopharm Therapeutics Inc. | 168.46M | 4.62% | 411,280 | 151.12M |
| 331 | MENS | Jyong Biotech Ltd. | 167.64M | 11.79% | 58,309 | - |
| 332 | ANTX | AN2 Therapeutics, Inc. | 163.78M | 1.56% | 81,327 | - |
| 333 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 162.29M | -8.04% | 324,504 | - |
| 334 | HRTX | Heron Therapeutics, Inc. | 160.53M | -1.31% | 1,838,229 | 150.71M |
| 335 | IMUX | Immunic, Inc. | 158.01M | -0.51% | 137,307 | - |
| 336 | ABOS | Acumen Pharmaceuticals, Inc. | 157.46M | - | 439,974 | - |
| 337 | HURA | TuHURA Biosciences, Inc. | 156.66M | -3.53% | 968,999 | - |
| 338 | PLX | Protalix BioTherapeutics, Inc. | 153.09M | -0.52% | 744,139 | 76.38M |
| 339 | PRQR | ProQR Therapeutics N.V. | 150.67M | -5.30% | 414,901 | 15.73M |
| 340 | SPRO | Spero Therapeutics, Inc. | 149.96M | 0.39% | 307,729 | 61.19M |
| 341 | PLYX | Polaryx Therapeutics, Inc. | 144.87M | 10.87% | 1,245,198 | - |
| 342 | NTHI | NeOnc Technologies Holdings, Inc. | 138.04M | 2.62% | 72,740 | 39.99K |
| 343 | KZIA | Kazia Therapeutics Limited | 138.04M | -3.82% | 271,261 | 1.27M |
| 344 | GALT | Galectin Therapeutics Inc. | 136.92M | -5.02% | 312,187 | - |
| 345 | TTRX | Turn Therapeutics Inc. | 135.54M | -7.14% | 59,357 | - |
| 346 | MOLN | Molecular Partners AG | 135.42M | -1.58% | 4,735 | 856.30K |
| 347 | OKUR | OnKure Therapeutics, Inc. | 133.31M | 7.14% | 243,908 | - |
| 348 | KRRO | Korro Bio, Inc. | 131.97M | -8.22% | 167,967 | 3.84M |
| 349 | SPRB | Spruce Biosciences, Inc. | 130.38M | -6.15% | 90,064 | 697.00K |
| 350 | GUTS | Fractyl Health, Inc. | 129.63M | 1.33% | 1,069,208 | 3.00K |
| 351 | ALPS | Alps Group Inc | 128.74M | -8.99% | 85,485 | 3.74M |
| 352 | AGEN | Agenus Inc. | 128.35M | -2.22% | 679,191 | 123.87M |
| 353 | ACOG | Alpha Cognition Inc. | 126.29M | 0.87% | 15,645 | 10.83M |
| 354 | GNLX | Genelux Corporation | 124.34M | -1.75% | 142,564 | 8.00K |
| 355 | CNTB | Connect Biopharma Holdings Limited | 123.78M | -7.98% | 130,336 | 233.00K |
| 356 | PYXS | Pyxis Oncology, Inc. | 120.37M | -5.20% | 260,997 | 13.86M |
| 357 | CRDF | Cardiff Oncology, Inc. | 120.33M | 4.14% | 3,143,134 | 525.00K |
| 358 | EQ | Equillium, Inc. | 111.59M | -4.08% | 214,495 | 4.39M |
| 359 | KLRS | Kalaris Therapeutics, Inc. | 108.06M | -0.84% | 21,311 | - |
| 360 | COYA | Coya Therapeutics, Inc. | 107.20M | -7.32% | 85,995 | 7.94M |
| 361 | EDSA | Edesa Biotech, Inc. | 106.18M | 32.78% | 1,050,091 | - |
| 362 | QTTB | Q32 Bio Inc. | 102.93M | 5.57% | 302,885 | 53.74M |
| 363 | ENGN | enGene Therapeutics Inc. | 102.49M | -2.55% | 1,424,175 | - |
| 364 | NRXP | NRx Pharmaceuticals, Inc. | 100.10M | -2.73% | 468,067 | 2.29M |
| 365 | INO | Inovio Pharmaceuticals, Inc. | 99.96M | - | 4,804,169 | 65.34K |
| 366 | CGTX | Cognition Therapeutics, Inc. | 99.18M | 1.83% | 548,618 | - |
| 367 | VANI | Vivani Medical, Inc. | 99.17M | 0.88% | 482,935 | - |
| 368 | CBUS | Cibus, Inc. | 99.17M | 1.56% | 452,389 | 4.29M |
| 369 | VRCA | Verrica Pharmaceuticals Inc. | 96.03M | -4.77% | 50,287 | 37.16M |
| 370 | PMN | ProMIS Neurosciences, Inc. | 95.51M | 2.06% | 13,656 | - |
| 371 | PEPG | PepGen Inc. | 95.45M | -6.12% | 842,310 | - |
| 372 | AARD | Aardvark Therapeutics, Inc. | 95.34M | 0.23% | 134,925 | - |
| 373 | LONA | LeonaBio, Inc. | 94.78M | -0.39% | 25,049 | - |
| 374 | SEER | Seer, Inc. | 94.50M | -0.89% | 454,653 | 15.17M |
| 375 | ALDX | Aldeyra Therapeutics, Inc. | 92.89M | -3.75% | 710,755 | - |
| 376 | ICCC | ImmuCell Corporation | 92.28M | 2.93% | 39,197 | 29.93M |
| 377 | PYPD | PolyPid Ltd. | 90.84M | 0.63% | 103,116 | - |
| 378 | PTHS | Pelthos Therapeutics Inc. | 90.60M | 3.25% | 61,909 | 27.70M |
| 379 | ONCY | Oncolytics Biotech Inc. | 90.00M | -3.14% | 716,850 | - |
| 380 | ANIX | Anixa Biosciences, Inc. | 89.52M | -3.26% | 101,996 | - |
| 381 | RANI | Rani Therapeutics Holdings, Inc. | 88.27M | -9.04% | 1,283,131 | 3.17M |
| 382 | BMEA | Biomea Fusion, Inc. | 88.21M | -2.40% | 1,094,014 | - |
| 383 | FBIO | Fortress Biotech, Inc. | 84.04M | 2.02% | 594,317 | 66.16M |
| 384 | OKYO | OKYO Pharma Limited | 83.97M | 0.63% | 36,777 | - |
| 385 | NRXS | NeurAxis, Inc. | 83.41M | -2.16% | 96,907 | 4.28M |
| 386 | CSBR | Champions Oncology, Inc. | 83.04M | -1.48% | 16,169 | 57.95M |
| 387 | EXOZ | eXoZymes, Inc. | 80.55M | -0.52% | 2,311 | -700.00 |
| 388 | ATRA | Atara Biotherapeutics, Inc. | 80.10M | 2.84% | 286,613 | 23.14M |
| 389 | RNTX | Rein Therapeutics Inc. | 77.65M | -4.33% | 986,098 | - |
| 390 | ACET | Adicet Bio, Inc. | 76.13M | -3.33% | 171,473 | - |
| 391 | RLYB | Rallybio Corporation | 75.06M | 0.64% | 90,286 | 858.00K |
| 392 | MAIA | MAIA Biotechnology, Inc. | 74.63M | -2.38% | 558,405 | - |
| 393 | OSTX | OS Therapies Incorporated | 73.99M | 1.73% | 501,360 | - |
| 394 | ATHE | Alterity Therapeutics Limited | 73.90M | -1.50% | 6,894 | 4.43M |
| 395 | XBIT | XBiotech Inc. | 72.26M | -1.25% | 21,168 | - |
| 396 | MCRB | Seres Therapeutics, Inc. | 72.05M | -1.98% | 28,054 | 1.15M |
| 397 | PLRX | Pliant Therapeutics, Inc. | 71.21M | -2.54% | 406,242 | - |
| 398 | PMVP | PMV Pharmaceuticals, Inc. | 69.86M | 4.80% | 580,119 | - |
| 399 | ACRV | Acrivon Therapeutics, Inc. | 68.48M | -3.03% | 508,456 | - |
| 400 | MNOV | MediciNova, Inc. | 68.42M | - | 21,285 | 596.64K |
| 401 | GANX | Gain Therapeutics, Inc. | 67.82M | -1.85% | 705,099 | - |
| 402 | ANVS | Annovis Bio, Inc. | 67.21M | -5.37% | 727,159 | - |
| 403 | CUE | Cue Biopharma, Inc. | 66.08M | -5.05% | 135,430 | 32.73M |
| 404 | IMMP | Immutep Limited | 65.80M | 1.80% | 908,727 | 5.28M |
| 405 | HYFT | MindWalk Holdings Corp. | 62.58M | - | 140,336 | 20.70M |
| 406 | ENTX | Entera Bio Ltd. | 62.52M | 3.25% | 30,038 | 42.00K |
| 407 | DWTX | Dogwood Therapeutics, Inc. | 61.79M | 8.82% | 53,206 | - |
| 408 | LIXT | Lixte Biotechnology Holdings, Inc. | 61.23M | 12.13% | 74,595 | - |
| 409 | IMA | ImageneBio, Inc. | 59.22M | -7.08% | 14,753 | 800.00K |
| 410 | IBO | Impact BioMedical Inc. | 58.04M | - | 20,103 | 39.00K |
| 411 | FLNA | Filana Therapeutics, Inc. | 57.97M | 0.84% | 200,855 | - |
| 412 | TCRX | TScan Therapeutics, Inc. | 57.88M | -3.69% | 598,945 | 9.14M |
| 413 | ACTU | Actuate Therapeutics, Inc. | 57.42M | -1.23% | 57,733 | - |
| 414 | PDSB | PDS Biotechnology Corporation | 55.82M | -15.25% | 1,622,147 | - |
| 415 | TIL | Instil Bio, Inc. | 54.73M | -0.74% | 59,825 | - |
| 416 | IBIO | iBio, Inc. | 54.22M | 5.63% | 779,352 | 300.00K |
| 417 | CING | Cingulate Inc. | 53.78M | -2.01% | 228,987 | - |
| 418 | BYSI | BeyondSpring Inc. | 53.04M | -7.53% | 38,999 | 1.88M |
| 419 | INKT | MiNK Therapeutics, Inc. | 51.56M | 3.09% | 51,061 | - |
| 420 | RADX | Radiopharm Theranostics Limited | 50.70M | -2.32% | 34,251 | 10.86M |
| 421 | XLO | Xilio Therapeutics, Inc. | 48.94M | 0.37% | 24,300 | 53.48M |
| 422 | HYPD | Hyperion DeFi, Inc. | 48.80M | 7.68% | 566,947 | 1.04M |
| 423 | ESLA | Estrella Immunopharma, Inc. | 48.64M | 1.79% | 25,138 | - |
| 424 | ATYR | aTyr Pharma, Inc. | 47.36M | -7.03% | 2,710,086 | 190.00K |
| 425 | MGX | Metagenomi Therapeutics, Inc. | 47.06M | -1.57% | 120,790 | 22.33M |
| 426 | KALA | KALA BIO, Inc. | 47.03M | -6.64% | 50,890 | - |
| 427 | GOSS | Gossamer Bio, Inc. | 46.73M | 3.32% | 26,028,958 | 55.54M |
| 428 | TELO | Telomir Pharmaceuticals, Inc. | 41.94M | 2.52% | 118,371 | - |
| 429 | NTRB | Nutriband Inc. | 41.94M | 0.88% | 1,374 | 2.04M |
| 430 | TVGN | Tevogen Bio Holdings Inc. | 41.33M | 11.15% | 40,726 | - |
| 431 | ATOS | Atossa Therapeutics, Inc. | 40.86M | -0.73% | 50,569 | - |
| 432 | PSTV | Plus Therapeutics, Inc. | 40.01M | -0.17% | 141,936 | 5.18M |
| 433 | LITS | Lite Strategy, Inc. | 39.63M | -0.46% | 222,259 | - |
| 434 | QNTM | Quantum BioPharma Ltd. | 39.31M | 11.64% | 335,955 | - |
| 435 | MREO | Mereo BioPharma Group plc | 37.99M | 0.25% | 1,314,975 | 500.00K |
| 436 | INMB | INmune Bio Inc. | 37.49M | -5.37% | 316,797 | 50.00K |
| 437 | RNXT | RenovoRx, Inc. | 36.31M | 2.90% | 273,864 | 1.49M |
| 438 | ATNM | Actinium Pharmaceuticals, Inc. | 35.85M | -1.71% | 57,531 | 90.00K |
| 439 | TVRD | Tvardi Therapeutics, Inc. | 34.80M | -7.25% | 34,732 | - |
| 440 | LTRN | Lantern Pharma Inc. | 34.64M | 3.00% | 118,094 | - |
| 441 | NNVC | NanoViricides, Inc. | 34.34M | 5.30% | 710,095 | - |
| 442 | VERU | Veru Inc. | 33.87M | -0.47% | 31,378 | 16.89M |
| 443 | GRCE | Grace Therapeutics, Inc. | 33.27M | -0.92% | 294,686 | - |
| 444 | EVAX | Evaxion A/S | 33.19M | -2.69% | 11,603 | 7.53M |
| 445 | NXTC | NextCure, Inc. | 32.94M | -1.30% | 40,000 | - |
| 446 | DARE | Daré Bioscience, Inc. | 32.76M | 6.64% | 543,249 | 1.16M |
| 447 | ALGS | Aligos Therapeutics, Inc. | 32.05M | -3.36% | 111,332 | 4.71M |
| 448 | BOLD | Boundless Bio, Inc. | 31.38M | -1.41% | 50,070 | - |
| 449 | APLM | Apollomics, Inc. | 31.18M | -5.33% | 15,760 | 8.84M |
| 450 | LSTA | Lisata Therapeutics, Inc. | 28.18M | - | 2,412 | 170.00K |
| 451 | BRNS | Barinthus Biotherapeutics plc | 27.92M | 7.05% | 19,310 | 14.97M |
| 452 | IGC | IGC Pharma, Inc. | 27.86M | -1.40% | 642,812 | 1.11M |
| 453 | KYNB | Kyntra Bio, Inc. | 27.53M | -0.44% | 11,008 | 7.44M |
| 454 | SNTI | Senti Biosciences Holdings, Inc. | 27.42M | -6.35% | 202,675 | 38.00K |
| 455 | PTN | Palatin Technologies, Inc. | 27.01M | -6.36% | 11,528 | 12.88M |
| 456 | NRSN | NeuroSense Therapeutics Ltd. | 26.94M | -1.08% | 151,358 | - |
| 457 | CRVO | CervoMed Inc. | 26.76M | -4.93% | 113,443 | 2.09M |
| 458 | ABVC | ABVC BioPharma, Inc. | 26.30M | -0.53% | 66,716 | 797.92K |
| 459 | DYAI | Dyadic International, Inc. | 26.27M | 0.12% | 66,055 | 3.81M |
| 460 | PLRZ | Polyrizon Ltd. | 26.17M | 1.97% | 17,121 | - |
| 461 | NEUP | Neuphoria Therapeutics Inc. | 25.71M | 1.06% | 174,444 | -13.27K |
| 462 | TPST | Tempest Therapeutics, Inc. | 25.53M | -2.20% | 94,199 | - |
| 463 | SKYE | Skye Bioscience, Inc. | 25.47M | -6.75% | 134,202 | - |
| 464 | PLUR | Pluri Inc. | 25.13M | -19.87% | 69,551 | 1.08M |
| 465 | VTGN | Vistagen Therapeutics, Inc. | 24.96M | 5.81% | 859,166 | 789.00K |
| 466 | TRAW | Traws Pharma, Inc. | 24.09M | -9.66% | 471,247 | 2.73M |
| 467 | SER | Serina Therapeutics, Inc. | 23.99M | 6.62% | 95,181 | 130.00K |
| 468 | OTLK | Outlook Therapeutics, Inc. | 23.89M | -0.35% | 2,657,323 | 333.14K |
| 469 | GRDX | GridAI Technologies Corp. | 23.87M | 1.85% | 52,046 | - |
| 470 | CELU | Celularity Inc. | 23.25M | 0.96% | 90,217 | 26.55M |
| 471 | MRKR | Marker Therapeutics, Inc. | 23.18M | - | 53,798 | 3.55M |
| 472 | ALLR | Allarity Therapeutics, Inc. | 23.04M | 4.20% | 177,501 | 345.00K |
| 473 | JSPR | Jasper Therapeutics, Inc. | 22.91M | 1.46% | 158,826 | - |
| 474 | VYNE | VYNE Therapeutics Inc. | 22.70M | 0.71% | 146,529 | 454.00K |
| 475 | AEON | AEON Biopharma, Inc. | 22.50M | 0.01% | 29,436 | - |
| 476 | SNSE | Sensei Biotherapeutics, Inc. | 22.48M | -15.77% | 51,469 | - |
| 477 | BCTX | BriaCell Therapeutics Corp. | 21.76M | 4.78% | 184,987 | - |
| 478 | HOWL | Werewolf Therapeutics, Inc. | 20.82M | -13.51% | 1,126,854 | 1.14M |
| 479 | LGVN | Longeveron Inc. | 19.71M | -0.41% | 308,237 | 1.22M |
| 480 | CRIS | Curis, Inc. | 19.02M | -0.87% | 156,097 | 7.06M |
| 481 | XCUR | Exicure, Inc. | 18.42M | -5.56% | 13,935 | 500.00K |
| 482 | CLRB | Cellectar Biosciences, Inc. | 17.93M | -2.55% | 487,937 | - |
| 483 | LPCN | Lipocine Inc. | 17.66M | -0.45% | 93,151 | 2.00M |
| 484 | KTTA | Pasithea Therapeutics Corp. | 17.52M | -8.75% | 317,476 | - |
| 485 | QNCX | Quince Therapeutics, Inc. | 17.44M | 7.56% | 1,782,059 | - |
| 486 | NCEL | NewcelX Ltd. | 17.12M | 2.25% | 3,943 | - |
| 487 | OSRH | OSR Holdings, Inc. | 16.89M | -2.45% | 850,165 | 2.63M |
| 488 | PASG | Passage Bio, Inc. | 16.30M | -0.78% | 12,491 | - |
| 489 | COCP | Cocrystal Pharma, Inc. | 15.85M | -2.54% | 148,123 | 225.00K |
| 490 | ICU | SeaStar Medical Holding Corporation | 15.55M | -2.75% | 36,073 | 1.44M |
| 491 | CVKD | Cadrenal Therapeutics, Inc. | 15.30M | 3.11% | 40,791 | - |
| 492 | CTXR | Citius Pharmaceuticals, Inc. | 15.02M | 5.16% | 624,067 | 5.61M |
| 493 | GNTA | Genenta Science S.p.A. | 14.70M | -1.35% | 24,174 | - |
| 494 | LEXX | Lexaria Bioscience Corp. | 14.31M | 3.07% | 68,149 | 368.00K |
| 495 | INAB | IN8bio, Inc. | 14.28M | 2.11% | 38,737 | - |
| 496 | GDTC | CytoMed Therapeutics Limited | 14.14M | -1.24% | 41,682 | 669.28K |
| 497 | HIND | Vyome Holdings, Inc. | 14.11M | 6.35% | 39,769 | 152.72K |
| 498 | GTBP | GT Biopharma, Inc. | 13.57M | 18.03% | 3,481,402 | - |
| 499 | BLRX | BioLineRx Ltd. | 13.48M | -5.90% | 1,468,935 | 1.18M |
| 500 | ERNA | Ernexa Therapeutics Inc. | 13.35M | -6.53% | 73,813 | 1,000.00 |